Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol

@inproceedings{Lambert2015GutMM,
  title={Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol},
  author={Jennifer E. Lambert and Jill A Parnell and Bertus Eksteen and Maitreyi Raman and Marc R. Bomhof and Kevin P. Rioux and Karen L Madsen and Raylene A Reimer},
  booktitle={BMC gastroenterology},
  year={2015}
}
BACKGROUND Evidence for the role of the gut microbiome in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) is emerging. Strategies to manipulate the gut microbiota towards a healthier community structure are actively being investigated. Based on their ability to favorably modulate the gut microbiota, prebiotics may provide an inexpensive yet effective dietary treatment for NAFLD. Additionally, prebiotics have established benefits for glucose control and potentially weight control… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 7 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 116 references

Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • 2007
View 14 Excerpts
Highly Influenced

Obesity and NAFLD: the role of bacteria and microbiota.

Clinics in liver disease • 2014
View 4 Excerpts
Highly Influenced

1761–72

Amar J Iglesias MA Poggi M Knauf C Bastelica D et al. M Cani PD, insulin resistance. Diabetes. 2007, 56
Lambert et al. BMC Gastroenterology • 2015